Abstract-Nitric oxide (NO) decreases cellular oxygen (O 2 ) consumption by competitively inhibiting cytochrome c oxidase. Here, we show that endogenously released endothelial NO, either basal or stimulated, can modulate O 2 consumption both throughout the thickness of conductance vessels and in the microcirculation. Furthermore, we have shown that such modulation regulates O 2 distribution to the surrounding tissues. We have demonstrated these effects by measuring O 2 consumption in blood vessels in a hypoxic chamber and O 2 distribution in the microcirculation using the fluorescent oxygen-probe Ru(phen) 3 2ϩ . Removal of NO by physical or pharmacological means, or in eNOS Ϫ/Ϫ mice, abolishes this regulatory mechanism. Our results indicate that, in addition to its well-known effect on the regulation of vascular tone, endothelial NO plays a major role in facilitating the distribution of O 2 , an action which is crucial for the adaptation of tissues, including the vessel wall itself, to hypoxia. It is possible that changes in the distribution of O 2 throughout the vessel wall may be implicated in the origin of vascular pathologies such as atherosclerosis. [eNOS]) is constantly activated by the shear stress generated by circulating blood. The resulting NO, which activates soluble guanylate cyclase (sGC), maintains a vasodilator tone which is determinant in the regulation of blood flow and pressure. 1 NO also interacts with the terminal enzyme of the electron transport chain, cytochrome c oxidase (CcO), in a manner that is competitive with oxygen (O 2 ), leading to an increase in the K m of this enzyme for O 2 and the consequent inhibition of respiration. 2 A number of studies in vascular endothelial cells 3 and in tissues 4,5 have shown that this results in a decrease in consumption of O 2 and in its redistribution away from mitochondria and toward other oxygen-dependent targets. 6 Thus NO plays a role in the subcellular profile of O 2 distribution. In this study, we have investigated this phenomenon by monitoring the dynamics of O 2 consumption and its distribution both in a variety of strips of conductance vessels from several species and in the mesenteric circulation of rats and mice. Our results indicate that NO plays a major role in facilitating O 2 distribution in these vascular tissues through its effect as an inhibitor of the mitochondrial CcO. This action, which increases as the O 2 concentration [O 2 ] decreases, might be a major factor in the adaptation of tissues to hypoxia.
N itric oxide (NO) synthase in the vasculature (endothelial NO synthase [eNOS] ) is constantly activated by the shear stress generated by circulating blood. The resulting NO, which activates soluble guanylate cyclase (sGC), maintains a vasodilator tone which is determinant in the regulation of blood flow and pressure. 1 NO also interacts with the terminal enzyme of the electron transport chain, cytochrome c oxidase (CcO), in a manner that is competitive with oxygen (O 2 ), leading to an increase in the K m of this enzyme for O 2 and the consequent inhibition of respiration. 2 A number of studies in vascular endothelial cells 3 and in tissues 4, 5 have shown that this results in a decrease in consumption of O 2 and in its redistribution away from mitochondria and toward other oxygen-dependent targets. 6 Thus NO plays a role in the subcellular profile of O 2 distribution. In this study, we have investigated this phenomenon by monitoring the dynamics of O 2 consumption and its distribution both in a variety of strips of conductance vessels from several species and in the mesenteric circulation of rats and mice. Our results indicate that NO plays a major role in facilitating O 2 distribution in these vascular tissues through its effect as an inhibitor of the mitochondrial CcO. This action, which increases as the O 2 concentration [O 2 ] decreases, might be a major factor in the adaptation of tissues to hypoxia.
Materials and Methods

Tissue Preparation
Human umbilical cords were obtained from the Department of Gynaecology and Obstetrics of the Hospital Doctor Peset. Vascular rings, 5 mm in length, were extracted from the middle portion of the cords. Male Sprague-Dawley rats (200 to 250 g, Harlan Laboratories, Barcelona, Spain) or wild-type (WT) and eNOS knockout (eNOS Ϫ/Ϫ ) mice (WT, C57BL/6Jx129, 20 to 25 g, UCL, London, UK) were decapitated and their thoracic aortas and pulmonary and mesenteric arteries were removed, cleaned of adhering tissues, and cut into 5-mm (rat vessels) or 2-mm (mouse vessels) rings. When necessary, the endothelium was disrupted by gently rubbing the luminal surface. For the experiments with fluorescence microscopy, a portion of the rat or mouse mesenteric arterial tree was isolated and cleaned of surrounding fat. All experiments were performed in Krebs solution (in 10 Ϫ3 mol/L) (NaCl 118, KCl 4.75, CaCl 2 1.9, MgSO 4 1.2, KH 2 PO 4 1.2, NaHCO 3 25, and glucose 10.1). All protocols complied with the European Community guidelines for the use of experimental animals and were approved by the Ethics Committee of the University of Valencia.
force-displacement transducers and recorded (Power Laboratory). An initial load of 2 g (aorta and human umbilical artery) or 1 g (pulmonary and mesenteric arteries) was applied to each preparation and maintained throughout the experiment. Following a 75-to 90-minute equilibration period, rings were contracted with phenylephrine (Phe) (1ϫ10 Ϫ5 mol/L in mesenteric artery or 1ϫ10 Ϫ6 mol/L in pulmonary artery, aorta, and human umbilical artery), and the presence of a functional endothelium was confirmed by eliciting a relaxant response (Ͼ95%) to acetylcholine (ACh) (1ϫ10 Ϫ5 mol/L), a dose that induces maximal sGC-mediated vasodilatation. 7 After a further equilibration period of 30 to 45 minutes, vessels were contracted with a depolarizing solution (60ϫ10 Ϫ3 mol/L KCl) to obtain the maximal level of contraction. After further washing, the rings were allowed to equilibrate for at least 1 hour. Thereafter, they were again stimulated with Phe and concentration-response curves of relaxation to ACh (1ϫ10 
Electrochemical Measurement of O 2 Consumption
Aortic rings from 2 rats (80 to 100 mg total wet weight) or 3 mice (20 to 30 mg wet weight), pulmonary and mesenteric rings from 3 rats (15 to 25 mg wet weight), or human umbilical arteries (190Ϯ5 mg total wet weight) were placed in gas-tight chambers containing 1 mL of Krebs solution and gently agitated at 37°C. In some cases, the viability of the rings was later assessed by confirming that their contractile response to Phe and their relaxant response to ACh did not differ from that of nonmanipulated vessels.
Visualization of Intracellular O 2 by Fluorescence Microscopy
Selected portions (Ϸ1.5ϫ1.5 cm) of the mesenteric arterial tree close to the gut were excised and incubated in the dark (3 hours) in Krebs solution (37°C) containing Tris(1,10-phenanthroline)ruthenium(II) chloride hydrate [Ru(phen) 3 2ϩ ] (1ϫ10 Ϫ4 mol/L). This fluorochrome has recently been adapted for use as an indicator of O 2 tension in cells and tissues, where its fluorescence is inversely proportional to the concentration of O 2 . 11,12 Ruthenium-based oxygen-sensing probes sense O 2 in the range of 0 to 9.1 ppm at 20°C, although their sensitivity range in tissues may differ at 37°C. 13 In addition to its strong visible absorption, efficient fluorescence, and relatively longlived excited state, Ru(phen) 3 2ϩ exhibits high O 2 sensitivity, a large Stoke shift, and high photo-/chemical stability in the cellular environment. Because of its long emission wavelength the fluorescence signal of the indicator is shifted away from cellular autofluorescence, which causes serious perturbation when UV sensing indicators are used. In our experimental conditions, ruthenium is taken up by living cells and maintains its O 2 -sensing properties for at least 5 hours after loading.
The vital cell nuclear stain Hoechst 33342 (1ϫ10 Ϫ6 mol/L) was added for the last 30 minutes of incubation. Samples of mesentery between 2 vessel branches were then mounted on a purpose-built support and transferred to a hypoxic incubator and maintained at 37°C. This system was then placed under a fluorescence microscope (Axiovert 200M Zeiss inverted 
Ϫ5 mol/L). Images (ϫ10 magnification) were obtained every 2 minutes throughout the entire experimental period, and changes in Ru(phen) 3 2ϩ fluorescence were analyzed using a 543-nm He-Ne laser to excite the probe. A 405-nm diode laser was used to excite Hoechst 33342. Fluorescence was detected through 440/20 BP and 604 LP filters for Hoechst 33342 and Ru(phen) 3 2ϩ , respectively, and the fluorescence microscope settings were adjusted to produce the optimum signal to noise ratio and maximum signal detection. An analysis of the ruthenium fluorescence in individual cells was obtained with Leica image analysis software that processed the image stacks acquired in the region of interest. The ratio of fluorescence intensity was calculated for each cell using imaging software (Leica Confocal Software, version 2.61, Leica Microsys- 
Data Analysis
Unless otherwise stated, all results are the meansϮSEM of at least 5 experiments from different animals. Statistical analysis was performed by 1-way ANOVA (GraphPad Software) and StudentNewman-Keuls as a post hoc test. Significance was defined as PϽ0.05.
Drugs and Solutions
Phe, ACh, Bk, L-NA, sodium cyanide, ODQ, meth(a)emoglobin, Ru(phen) 3 2ϩ , and Hoechst 33342 were acquired from Sigma-Aldrich (St Louis, Mo). DETA-NO was from Alexis (Lausen, Switzerland). OxyHb was prepared by reduction of human meth(a)emoglobin with a 10-fold molar excess of sodium dithionite, followed by dialysis against PBS. All drugs were dissolved in ultrapure water. Ru(phen) 3 2ϩ and Hoechst 33342 were dissolved in Krebs solution and ODQ was dissolved in DMSO (1:5000 vol:vol).
Results
Consumption of O 2 by Blood Vessels
First we monitored VO 2 in several isolated blood vessels when placed in an O 2 -tight chamber, as previously described. 7 Table) . This action of NO was independent of an effect on sGC because it was unaffected by treatment with the specific sGC inhibitor ODQ (Table) . Figure 1C shows the consumption of O 2 at 2 specific [O 2 ] that approximate to those of arterial blood (130ϫ10 Ϫ6 mol/L) and tissue (30ϫ10 Ϫ6 mol/L), respectively. 7, 8 Aortas were found to consume Ϸ50% less O 2 at the lower of the 2 [O 2 ]. This NO-dependent adaptive response was not observed only in the aorta but in all the vessels studied, independent of species (human, rat, mouse) or anatomic origin (placental, systemic, or pulmonary circulation) (Table) .
In aortas from eNOS knockout mice, we observed a reduced apparent K m for O 2 and similar rates of O 2 consumption at the high and low [O 2 ] studied. This contrasted with the response of tissues from WT mice, which was similar to that of control rat aortas. The responses of tissues from the eNOS knockout mice were similar to those exhibited by WT controls after treatment with L-NA or endothelium denudation ( Figure 1D through 1F Table) . This did not occur when the tissues were treated with L-NA or were endothelium-denuded ( Figure 2B ). Unlike ACh or Bk, the greater inhibition of O 2 consumption and the increase in the K m values induced by the slow-releasing NO donor DETA-NO (1ϫ10 Ϫ5 mol/L) were not significantly affected either by inhibition of NO production or by removal of the endothelium ( Figure 2B ). The fact that the potent vasoconstrictor Phe (EC 95 ) (1ϫ10 Ϫ5 mol/L in mesenteric artery or 1ϫ10 Ϫ6 mol/L in pulmonary artery, aorta and human umbilical artery) also induced an NO-dependent decrease in the vascular consumption of O 2 (Table) ruled out the possibility that the action of ACh, Bk, and DETA-NO was attributable to their vasodilator properties.
Concentration of O 2 in Vascular Tissue
We used the O 2 probe Ru(phen) 3 2ϩ (1ϫ10 Ϫ4 mol/L) to monitor O 2 concentrations under normal and hypoxic conditions in ex vivo portions of rat mesenteric tissue containing at least one blood vessel of Ϸ20 to 30 m in diameter. The tissue was placed on a purpose-built support inside a chamber and analyzed under a fluorescence microscope in continuously regulated conditions of temperature (37°C) and gas (5% CO 2 Figure 3A and 3B and Online Movies), indicating that it was NO-dependent and that an active NO synthase was generating NO at concentrations sufficient to modulate the consumption of O 2 14 and divert it toward the surrounding tissues. This is supported by the fact that sodium cyanide, which also inhibits the CcO, produced a similar increase in the concentration of Ϫ6 mol/L O 2 also elicited a decrease in ruthenium fluorescence that was smaller than that observed in hypoxia but was still significant ( Figure 4A and 4B and Online Movies). This response was substantially enhanced if hypoxia was induced subsequently. Treatment with L-NA prevented the effects of ACh ( Figure 4B ) but had no effect on the similar response induced by DETA-NO (1ϫ10 Ϫ5 mol/L) (data not shown). Experiments in eNOS knockout mice further showed that, whereas mesenteric tissues from WT mice exhibited a similar NO-dependent increase in the concentration of tissue O 2 to that obtained in rats, those from eNOS knockout animals showed no changes in fluorescence during hypoxia ( Figure 3A and 3C and Online Movies), even after the administration of ACh (data not shown).
Discussion
Our results indicate that both basal and stimulated release of NO from the vascular endothelium is responsible not only for the well-known regulation of vascular tone 1 but also for the adjustment of O 2 consumption. In our experiments using isolated blood vessels, although we studied the consumption of O 2 This modulatory effect of NO was observed in a variety of vessels of different anatomic origin and sources, including human, and is consistent with its known effect in reducing the When endothelial NO generation was increased with ACh or Bk, at concentrations at which these agonists produced potent sGC-mediated vasodilation, 16 there was an enhanced reduction in VO 2 . This occurred even at the higher [O 2 ] and was also prevented by treatment with L-NA or removal of the endothelium. Administration of exogenous NO with DETA-NO also induced a greater inhibition of O 2 consumption and increase in K m , which were not affected either by inhibition of NO generation or by removal of the endothelium. These results are in accordance with previous observations in cells 3, 9 and in tissues. 4, 7, 17 This NO-dependent effect on consumption of O 2 was also observed in the presence of the vasoconstrictor Phe, which is known to release NO following activation of endothelial ␣ 1 adrenoreceptors. 18 Inhibition of CcO by NO (a phenomenon that has been called "metabolic hypoxia" 8 ) leads to a major redistribution of O 2 , which has been demonstrated in cells in culture. 6, 19 Our results, obtained with fluorescence microscopy show that this redistribution also occurs in vascular tissues in vitro. Indeed, these experiments show that the stimulation of endothelial NO production with ACh resulted in an increase in the intracellular [ 6, 20, 21 It may also occur in the larger vessels, where the requirement for O 2 by the vascular smooth muscle may vary as a result of the action of hormones such as ACh and adrenaline, as well as the activity of the different sets of nerves that innervate the vasculature. This remains to be studied. In addition, it is possible that changes in the distribution of O 2 throughout the vessel wall, because of a decrease in NO production in endothelial dysfunction, may play a role in the development of vascular disease.
